Vilon 20 mg

Vilon is a synthetic short peptide bioregulator developed within the Khavinson school of peptide research. It is composed of a defined dipeptide sequence (Lys-Glu, also referred to as KE) and is classified among the low molecular weight regulatory peptides studied for their organ-specific signaling activity. Due to its minimal structure, Vilon serves as a useful model compound for investigating how short peptides interact with cellular regulatory machinery in immune and lymphoid research environments.

Mechanistically, Vilon is investigated for its capacity to influence chromatin decondensation and gene expression in lymphoid cells. Experimental research models indicate that the KE dipeptide can penetrate cellular and nuclear membranes, interact with DNA-associated regulatory regions, and modulate transcriptional activity in genes connected to immune signaling, lymphocyte proliferation, and adaptive immune balance. These regulatory effects position Vilon as a peptide of interest for studies of epigenetic modulation rather than direct receptor agonism.

Research interest in Vilon has centered on immunomodulatory signaling, age-related immune decline, and chromatin-level gene expression regulation in lymphocyte research models. Investigations have also explored its interaction with thymus-derived peptides such as Thymogen and Thymalin, examining how short dipeptide bioregulators may support immune homeostasis in experimental conditions involving stress, aging, and impaired immune responsiveness (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The study of short peptide bioregulators originated within the Khavinson school of gerontology, where researchers identified that defined amino acid sequences extracted from animal tissues could regulate cellular function in an organ-specific manner. Among these early findings, Lys-Glu was characterized as a dipeptide associated with immune and lymphoid tissue regulation, later synthesized for controlled experimental use as Vilon.

Vilon was developed as a minimal yet biologically active dipeptide that retains regulatory activity while offering enhanced stability and reproducibility for research. Its compact structure allows for investigations into how very short peptides may cross cellular membranes, reach nuclear chromatin, and influence gene transcription patterns in lymphocyte and thymus-related research models.

Ongoing research has positioned Vilon alongside other Khavinson-school bioregulators such as Thymogen and Epitalon, contributing to a broader investigation into peptide-mediated epigenetic regulation, age-associated immune balance, and the molecular foundations of lymphoid cellular communication.

1. Chromatin Decondensation

Vilon is studied for its ability to interact with chromatin organization at the nuclear level. Experimental observations suggest that the KE dipeptide can promote local chromatin decondensation, exposing regulatory DNA regions to transcriptional machinery and supporting gene expression changes associated with lymphocyte activity.

2. Gene Expression Regulation

Research models indicate that Vilon may modulate the expression of genes involved in immune signaling, lymphocyte differentiation, and adaptive immune responses. These effects reflect a regulatory mode of action rather than direct receptor-mediated stimulation, supporting its classification as a peptide bioregulator.

3. Immune Signaling Modulation

Vilon has been examined for its influence on immune-cell communication pathways, including cytokine-related signaling and lymphocyte proliferation balance. Experimental data suggest a normalizing effect on immune activity in research models involving stress, aging, or impaired immune responsiveness.

4. Interaction with Thymus-Derived Peptides

Vilon is frequently studied alongside thymic peptides such as Thymogen and Thymalin. Comparative investigations explore how short bioregulators may complement one another in influencing thymic function, lymphoid tissue regulation, and adaptive immune balance.

Research Applications

Conclusion

Vilon is a Khavinson-school dipeptide bioregulator studied for its capacity to influence chromatin organization, gene expression, and immune signaling in lymphocyte research models. Its regulatory nature distinguishes it from direct-acting agents and supports its continued investigation as a research compound for immunomodulation, epigenetic studies, and age-associated immune balance.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.